These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2991580)

  • 61. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
    Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
    J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differences in inhibition of replication between Coxsackie B4 virus strains in various cell lines by antibodies to some cell surface proteins.
    Frisk G; Jansson K; Ericsson M; Diderholm H
    Virus Res; 2001 Mar; 73(2):121-30. PubMed ID: 11172916
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Poliovirus metabolism and the cytoskeletal framework: detergent extraction and resinless section electron microscopy.
    Weed HG; Krochmalnic G; Penman S
    J Virol; 1985 Nov; 56(2):549-57. PubMed ID: 2997475
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism.
    Selinka HC; Wolde A; Sauter M; Kandolf R; Klingel K
    Med Microbiol Immunol; 2004 May; 193(2-3):127-31. PubMed ID: 12920584
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Receptor proteins on newborn Balb/c mouse brain cells for coxsackievirus B3 are immunologically distinct from those on HeLa cells.
    Xu R; Mohanty JG; Crowell RL
    Virus Res; 1995 Mar; 35(3):323-40. PubMed ID: 7785319
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Isolation of a receptor protein involved in attachment of human rhinoviruses.
    Tomassini JE; Colonno RJ
    J Virol; 1986 May; 58(2):290-5. PubMed ID: 3009846
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sedimentation behavior of solubilized gonadotropin receptor from plasma membranes of bovine corpus luteum.
    Thambyrajah V; Azhar S; Menon KM
    Biochim Biophys Acta; 1976 Mar; 428(1):35-44. PubMed ID: 177061
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection.
    Pinkert S; Röger C; Kurreck J; Bergelson JM; Fechner H
    J Virol; 2016 Jun; 90(12):5601-5610. PubMed ID: 27030267
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cleavage of poliovirus-specific polypeptide aggregates.
    Korant BD
    J Virol; 1973 Sep; 12(3):556-63. PubMed ID: 4355854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
    Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A
    Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
    Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
    J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virions.
    Roivainen M; Alakulppi N; Ylipaasto P; Eskelinen M; Paananen A; Airaksinen A; Hovi T
    J Virol Methods; 2005 Dec; 130(1-2):108-16. PubMed ID: 16055201
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection.
    Zautner AE; Körner U; Henke A; Badorff C; Schmidtke M
    J Virol; 2003 Sep; 77(18):10071-7. PubMed ID: 12941917
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Liposome-mediated transient transfection reduces cholesterol-dependent coxsackievirus infectivity.
    Wong J; Zhang J; Gao G; Esfandiarei M; Si X; Wang Y; Yanagawa B; Suarez A; McManus B; Luo H
    J Virol Methods; 2006 May; 133(2):211-8. PubMed ID: 16375979
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells.
    Funke C; Farr M; Werner B; Dittmann S; Überla K; Piper C; Niehaus K; Horstkotte D
    J Gen Virol; 2010 Aug; 91(Pt 8):1959-1970. PubMed ID: 20392896
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interaction of poliovirus with its purified receptor and conformational alteration in the virion.
    Arita M; Koike S; Aoki J; Horie H; Nomoto A
    J Virol; 1998 May; 72(5):3578-86. PubMed ID: 9557638
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor.
    Werk D; Schubert S; Lindig V; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
    Biol Chem; 2005 Sep; 386(9):857-63. PubMed ID: 16164410
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CVB translation: lessons from the polioviruses.
    Bonderoff JM; Lloyd RE
    Curr Top Microbiol Immunol; 2008; 323():123-47. PubMed ID: 18357768
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of protein trafficking by coxsackievirus b3: multiple viral proteins target a single organelle.
    Cornell CT; Kiosses WB; Harkins S; Whitton JL
    J Virol; 2006 Jul; 80(13):6637-47. PubMed ID: 16775351
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Replication of Western equine encephalomyelitis virus. II. Cytoplasmic structure involved in the synthesis and development of the virions.
    Sreevalsan T; Allen PT
    J Virol; 1968 Oct; 2(10):1038-46. PubMed ID: 5723707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.